First-Trimester Combined Screening Is Effective for the Detection of Unbalanced Chromosomal Translocations at 11 to 12 Weeks of Gestation

Abstract

The first trimester combined screening, which analyzes fetal nuchal translucency and levels of free β-human chorionic gonadotropin (β-hCG) and pregnancy-associated plasma protein A (PAPP-A) in maternal serum, is routinely used to detect abnormal pregnancies associated with Down syndrome and other trisomy aneuploidies. Based on the hypothesis that major chromosomal translocations could lead to similar biochemical and developmental outcomes during early embryo development, we compared these markers among pregnancies with normal, balanced, or unbalanced fetal karyotypes. Among the parents, 71 (73%) carry balanced reciprocal translocation and 26 (27%) have Robertsonian translocation. Of the 97 pregnancies tested, 39 (40%), 37 (37%), and 22 (23%) fetuses had normal karyotype, balanced chromosomal translocations, and unbalanced chromosomal translocations, respectively. Importantly, we found that pregnancies with an unbalanced translocation had significantly higher free β-hCG multiple of the median (MoM) and larger nuchal translucency thickness than those with normal karyotype or balanced translocations. Analysis showed that the area under a receiver operating characteristic curve (AUC) is 0.716, 0.820, and 0.936 for free β-hCG MoM, PAPP-A MoM, and fetal nuchal translucency, respectively. When these 3 independent factors were combined, the AUC reached 0.976. In addition, logistic regression showed that the most optimal model for predicting an unbalanced chromosomal translocation is a combination of PAPP-A and nuchal translucency with an AUC of 0.980. Therefore, the first trimester combined screening is not only effective in the screening of Down syndrome and other trisomy abnormalities but also has high sensitivity for the detection of unbalanced chromosomal translocations in fetuses.

Keywords

chromosomal translocation nuchal translucency first trimester combined screening β-hCG PAPP-A.

Get full access to this article

View all access options for this article.

References

Michels

Medrano

Venne

Riccardi

. Chromosome translocations in couples with multiple spontaneous abortions. Am J Hum Genet. 1982;34(3):507–513.

Lippman-Hand

Vekemans

. Balanced translocations among couples with two or more spontaneous abortions: are males and females equally likely to be carriers? Hum Genet. 1983;63(3):252–257.

Wang

Zhen

Zilberstein

Falco

Bianchi

. Non-invasive exclusion of fetal aneuploidy in an at-risk couple with a balanced translocation. Mol Hum Reprod. 2000;6(2):103–106.

Nicolaides

Spencer

Avgidou

Faiola

Falcon

. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol. 2005;25(3):221–226.

Cheng

Huang

Shaw

Chueh

Hsiao

Hsieh

. Effect of maternal hepatitis B carrier status on first-trimester markers of Down syndrome. Reprod Sci. 2010;17(6):564–567.

Cheng

Huang

Shaw

Chueh

Hsieh

. Maternal homocysteine level and markers used in first-trimester screening for fetal Down syndrome. Reprod Sci. 2010;17(12):1130–1134.

Cheng

Chang

Shaw

Soong

. Nuchal translucency thickness in fetuses with chromosomal translocation at 11-12 weeks of gestation. Obstet Gynecol. 2005;105(5 pt 1):1058–1062.

Conover

Oxvig

Overgaard

Christiansen

Giudice

. Evidence that the insulin-like growth factor binding protein-4 protease in human ovarian follicular fluid is pregnancy associated plasma protein-A. J Clin Endocrinol Metab. 1999;84(12):4742–4745.

Lawrence

Oxvig

Overgaard

. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci U S A. 1999;96(6):3149–3153.

10.

Brambati

Macintosh

Teisner

. Low maternal serum levels of pregnancy associated plasma protein A (PAPP-A) in the first trimester in association with abnormal fetal karyotype. Br J Obstet Gynaecol. 1993;100(4):324–326.

11.

Macintosh

Brambati

Chard

Grudzinskas

. Predicting fetal chromosome anomalies in the first trimester using pregnancy associated plasma protein-A: a comparison of statistical methods. Methods Inf Med. 1993;32(2):175–179.

12.

Brizot

Snijders

Bersinger

Kuhn

Nicolaides

. Maternal serum pregnancy-associated plasma protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy. Obstet Gynecol. 1994;84(6):918–922.

13.

Macintosh

Iles

Teisner

. Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A, markers for fetal Down syndrome at 8-14 weeks. Prenat Diagn. 1994;14(3):203–208.

14.

Brizot

Hyett

Mckie

Bersinger

Farzaneh

Nicolaides

. Gene expression of human pregnancy-associated plasma protein-A in placenta from trisomic pregnancies. Placenta. 1996;17(1):33–36.

15.

Ochshorn

Kupferminc

Wolman

Orr-Urtreger

Jaffa

Yaron

. First trimester PAPP-A in the detection of non-Down syndrome aneuploidy. Prenat Diagn. 2001;21(7):547–549.

16.

Smith

Stenhouse

Crossley

Aitken

Cameron

Connor

. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab. 2002;87(4):1762–1767.

17.

Dugoff

Hobbins

Malone

. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol. 2004;191(4):1446–1451.

18.

Morrish

Marusyk

Siy

. Demonstration of specific secretory granules for human chorionic gonadotropin in placenta. J Histochem Cytochem. 1987;35(1):93–101.

19.

Hay

. Placental histology and the production of human choriogonadotropin and its subunits in pregnancy. Br J Obstet Gynaecol. 1988;95(12):1268–1275.

20.

Jameson

Hollenberg

. Regulation of chorionic gonadotropin gene expression. Endocr Rev. 1993;14(2):203–221.

21.

Jauniaux

Nicolaides

Nagy

Brizot

Meuris

. Total amount of circulating human chorionic gonadotrophin alpha and beta subunits in first trimester trisomies 21 and 18. J Endocrinol. 1996;148(1):27–31.

22.

Spencer

. Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review. Br J Obstet Gynaecol. 1999;106(12):1287–1293.

23.

Spencer

Berry

Crossley

Aitken

Nicolaides

. Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy? Prenat Diagn. 2000;20(4):311–317.

24.

Kagan

Wright

Baker

Sahota

Nicolaides

. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol. 2008;31(6):618–624.

25.

Ozturk

Milunsky

Brambati

Sachs

Miller

Wands

. Abnormal maternal serum levels of human chorionic gonadotropin free subunits in trisomy 18. Am J Med Genet. 1990;36(4):480–483.

26.

Spencer

Nicolaides

. A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free beta-hCG and PAPP-A. Prenat Diagn. 2002;22(10):877–879.

27.

Daniel

Hook

Wulf

. Risks of unbalanced progeny at amniocentesis to carriers of chromosome rearrangements: data from United States and Canadian laboratories. Am J Med Genet. 1989;33(1):14–53.

28.

Pettenati

Rao

Phelan

. Paracentric inversions in humans: a review of 446 paracentric inversions with presentation of 120 new cases. Am J Med Genet. 1995;55(2):171–187.

29.

Hume

Jr Kilmer-Ernst

Wolfe

. Prenatal cytogenetic abnormalities: correlations of structural rearrangements and ultrasonographically detected fetal anomalies. Am J Obstet Gynecol. 1995;173(4):1334–1336.

30.

Ruiz

Grubs

Jewett

. Prenatally diagnosed de novo apparently balanced complex chromosome rearrangements: two new cases and review of the literature. Am J Med Genet. 1996;64(3):478–484.